Metraipolis › archive › dc_05e88a910bea
Leveraging artificial intelligence to validate traditional biomarkers and drug targets in liver cancer recovery: a mini review — Europe PMC PMID:41181592
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41181592
- DOI
- 10.3389/fphar.2025.1697608
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T05:29:20.088Z
- SHA-256 of the archived text
9426a436ea0599d6f3230d9ba1377d4a3845fa3f714db02ea3a9e59f4132f84c- Stable URL of this page
https://metraipolis.com/documento/dc_05e88a910bea
How to cite
Leveraging artificial intelligence to validate traditional biomarkers and drug targets in liver cancer recovery: a mini review — Europe PMC PMID:41181592 — Europe PMC (en), https://europepmc.org/article/MED/41181592 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05e88a910bea (Metraipolis archive dc_05e88a910bea, sha256 9426a436ea0599d6f3230d9ba1377d4a3845fa3f714db02ea3a9e59f4132f84c)
BibTeX
@misc{dc05e88a910bea,
title = {Leveraging artificial intelligence to validate traditional biomarkers and drug targets in liver cancer recovery: a mini review — Europe PMC PMID:41181592},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41181592},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05e88a910bea; sha256 9426a436ea0599d6f3230d9ba1377d4a3845fa3f714db02ea3a9e59f4132f84c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41181592. Agents can read the archived copy with the MCP tool read_document.